Skip to content

A Clinical trial on Kuppaimeni Chooranam in the management of RATHTHA MOOLAM (BLEEDING HEMORRHOIDS)

A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON- RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF KUPPAIMENI CHOORANAM IN THE MANAGEMENT OF RATHTHA MOOLAM (BLEEDING HEMORRHOIDS)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052275
Enrollment
40
Registered
2023-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids

Interventions

Intervention1: KUPPAIMENI CHOORANAM: 1gm twice a day (orally) with water for 45 days. Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who will be having classical symptoms of bleeding piles (1st degree Internal Hemorrhoids) i.e. constipation, Bleeding per anus, Itching in the perianal region. 2.Patients who are all willing to give blood samples at subsequent visit are involved in this study.

Exclusion criteria

Exclusion criteria: 1.Patients of age below 18 years and above 60 years. 2.Patient having 2nd, 3rd degree internal haemorrhoids,Pregnancy,Fissure in ano,Fistula in ano,Diabetes mellitus,Systemic Hypertension. Rectal Malignancy

Design outcomes

Primary

MeasureTime frame
Of during and after treatment and reduction in clinical symptoms of bleeding during defecation, constipation after defecation, pruritus ani.Timepoint: 45 days

Secondary

MeasureTime frame
1.To evaluate the pharmacological activities of trial drug. 2.Study about the prevalence of RATHA MOOLAM in relation between diet and lifestyle. 3.To determine antimicrobial activity of trail drug in different solvents. 4.To find out primary phytochemical analysis in trail drug. 5.To evaluate proctoscopical changes in internal haemorrhoids. 6.To evaluate safety profile for acute and subacute toxicity. 7.To perform bio chemical analysis.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr A Manoharan MDsPhD

Government Siddha Medical College and Hospital

drpsk_md@yahoo.in9944337757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026